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An 83-year-old male resident of a local frail care centre pre-
sented with a background history of urinary retention, for which
an indwelling latex urethral catheter had been inserted seven weeks
before.
On examination, no significant abnormalities were detected, except
for a purple-stained urine bag (Fig. 1). Further questioning relat-
ing to the patient’s bowel habits revealed that he had been having
significant episodes of constipation spanning over a period of two
months. Haematological investigations failed to reveal any signifi-
cant abnormality, while urine microscopy and culture revealed the
presence of Enterococcus  faecalis  and Kebsiella  pneumonia.
On the background of the chronic constipation in an elderly patient,
the duration of the indwelling urethral catheter, purple discoloura-
tion of the urine collection bag and the urine culture result a
diagnosis of the ‘purple urine bag syndrome’ (PUBS) was made.
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The patient was successfully managed with oral ciprofloxacin, cor-
rection of his dietary and fluid habits, addition of a stool softener
and changing the urinary collecting system under sterile conditions.
We plan on initiating a trial of a prostate selective alpha-blocker,
should the urinary retention persist after correction of the underlying
constipation.
Discussion
Since the first report of PUBS in 1978 [1], it has remained a rare
and fascinating condition that has since proven to be associated with
chronic constipation, an alkaline urinary pH, a bed-ridden state,
advanced age, tryptophan rich foods, cognitive disorders, renal dys-
function and chronic urethral catheterization. Urinary tract infection
with various bacterial strains including the Enterococcus  species,
Escherichia  coli  and K.  pneumonia  have been implicated [2–4].
This phenomenon is a manifestation of a cascade of metabolic reac-
tions (Fig. 2), beginning with the intestinal bacterial interaction with
the tryptophan in food. Once deaminated, tryptophan forms indole
which is converted to indoxyl potassium sulphate in the liver. Bac-
terial phosphatases or sulfatases produced within the urinary tract
convert indoxyl potassium sulphate to indoxyl, which after being
exposed to alkaline urine is further converted into indigo (blue) and
indirubin (red). It is the reaction of these two pigments that interact
with the constituents of the urinary bag to form the alarming purple
discolouration [2,5].
Although PUBS is mostly a benign process, some authors advise
initiation of short course antibiotic therapy, with the changing of
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Figure  1  The purple-stained urine bag.
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Figure  2  Diagram demonstrating the metabolic cascade responsible
for the Purple Urine Bag Syndrome.
the urinary collecting system [2–4]. Optimisation of dietary habits
and bowel function along with the prevention of catheter-associated
urinary tract infection will also assist in avoiding this condition from
occurring [5].
Close surveillance amongst immune-compromised patients with
PUBS is advised, since the life-threatening complication of
Fournier’s gangrene has been previously reported amongst this sub-
set of patients [6].
Consent
Written consent had been obtained from the patient.
Conflict  of  interest
None declared.
Acknowledgement
We wish to thank Drs E. Hoosien and S. Muhammad, from the
Medical Microbiology Department at the University of Pretoria, Pre-
toria, South Africa, for their assistance with the above microbiology
reports.
References
[1] Barlow GB, Dickson JAS. Purple urine bags. Lancet 1978;311:
220–1.
[2] Lin CH, Huang HT, Chien CC, Tzeng DS, Lung FW. Purple urine bag
syndrome in nursing homes: ten elderly case reports and a literature
review. Clin Interv Aging 2008;3:729–34.
[3] Mantani N, Ochiai H, Imanishi N, Kogure T, Terasawa K, Tamura J. A
case-control study of purple urine bag syndrome in geriatric wards. J
Infect Chemother 2003;9:53–7.
[4] Ga H, Kojima T. Purple urine bag syndrome. JAMA 2012;307:
1912–3.
[5] Hadano Y, Shimizu T, Takada S, Inoue T, Sorano S. An update
on purple urine bag syndrome. Int J Gen Med 2012;(5):707–10,
http://dx.doi.org/10.2147/IJGM.S35320.
[6] Tasi YM, Huang MS, Yang CJ, Yeh SM, Liu CC. Purple urine bag
syndrome, not always a benign process. Am J Emerg Med 2009;27:
895–7.
